Changes to the Code
S. 355 · FDA Modernization Act 3.0 · Engrossed The official text as one chamber (House or Senate) passed it.
Passed the Senate · step 3 of 5
21 U.S.C. § 355 New drugs
Couldn't place the change
The bill's words for this section
- Not carried out:
Section 505 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355) is amended by designating the second subsection (z) (relating to clinical trial diversity action plans), as added by section 3601(a) of the Health Extenders, Improving Access to Medicare, Medicaid, and CHIP, and Strengthening Public Health Act of 2022 (division FF of Public Law 117–328), as subsection (aa).
We can't read how this instruction is worded yet, so it isn't shown in the text.
Technical detail
no-pattern: designating the second subsection (X) (relating to clinical trial diversity action plans), as added by section N (X) of the health extenders, improving access to medicare, medicaid, and chip, and strengthening public health act of N (division ff of REF), as subsection (X).